IL1B and nasopharyngeal carcinoma: Additionally, survival analysis showed that the 5-year distant metastatic rate of patients with NPC and higher serum IL-1β levels was significantly lower than that of patients with NPC and lower IL-1β concentration, indicating that patients with NPC and a higher serum IL-1β concentration were prone to metastasis (Fig. 6E).